Core Viewpoint - The company, Bluestar Medical (002382), announced that its subsidiary, NVT GmbH in Germany, has received CE certification for its next-generation recyclable transcatheter aortic valve replacement (TAVR) delivery system, IMPERIA [1] Company Summary - Bluestar Medical's cardiovascular division has successfully developed a new TAVR delivery system [1] - The IMPERIA system is designed to be recyclable, indicating a focus on sustainability in medical device development [1] Industry Summary - The receipt of CE certification allows the IMPERIA system to be marketed in the European Union, which is a significant milestone for the company and its product [1] - This development reflects ongoing innovation in the cardiovascular medical device industry, particularly in minimally invasive procedures [1]

蓝帆医疗股份有限公司 公开发行可转换公司债券 2025 年跟踪评级报告 1 www.lhratings.com 联合〔2025〕5291 号 联合资信评估股份有限公司通过对蓝帆医疗股份有限公司主体 及其相关债券的信用状况进行跟踪分析和评估，确定下调蓝帆医疗 股份有限公司主体长期信用等级为 AA-，下调"蓝帆转债"信用等级 为 AA-，评级展望为稳定。 特此公告 联合资信评估股份有限公司 评级总监： 二〇二五年六月二十七日 跟踪评级报告 | 2 三、本报告引用的资料主要由该公司或第三方相关主体提供，联合资信 履行了必要的尽职调查义务，但对引用资料的真实性、准确性和完整性不作 任何保证。联合资信合理采信其他专业机构出具的专业意见，但联合资信不 对专业机构出具的专业意见承担任何责任。 四、本次跟踪评级结果自本报告出具之日起至相应债券到期兑付日有 效；根据跟踪评级的结论，在有效期内评级结果有可能发生变化。联合资信 保留对评级结果予以调整、更新、终止与撤销的权利。 五、本报告所含评级结论和相关分析不构成任何投资或财务建议，并且 不应当被视为购买、出售或持有任何金融产品的推荐意见或保证。 六、本报告不能取代任何机构或个人 ...

| 证券代码：002382 | 证券简称：蓝帆医疗 | 公告编号：2025-053 | | --- | --- | --- | | 债券代码：128108 | 债券简称：蓝帆转债 | | 蓝帆医疗股份有限公司 关于子公司新一代可回收经导管主动脉瓣置换术输送系统 获得 CE 证书的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、 误导性陈述或重大遗漏。 近日，蓝帆医疗股份有限公司（以下简称"公司"）接到通知，公司心脑血管事业 部旗下子公司德国NVT GmbH研发的新一代可回收经导管主动脉瓣置换术（TAVR）输 送系统IMPERIA™（以下简称"IMPERIA™输送系统"）获得欧盟CE认证，该输送系统 用于搭配公司旗下已上市的ALLEGRA™系列主动脉瓣膜使用以实现可回收功能。现将 相关情况公告如下： TAVR手术通过股动脉送入介入导管，将人工心脏瓣膜输送至主动脉瓣区打开，完 成人工瓣膜置入、恢复瓣膜功能。TAVR手术无需开胸、创伤小、术后恢复快，为不能 手术的严重主动脉瓣狭窄患者提供了显著提高生活质量的选项。 一、获批产品基本信息 产品名称：IMPERIA Delivery Sys ...

Group 1 - The company held its 24th meeting of the 6th Board of Directors on June 19, 2025, via electronic communication, with all 8 directors participating [1] - The meeting confirmed that the company's stock had closed below 85% of the current conversion price for at least 15 out of the last 30 trading days, triggering the condition for downward adjustment of the "Lanfan Convertible Bonds" conversion price [1][2] - The Board proposed to adjust the conversion price of the "Lanfan Convertible Bonds" downward, which requires approval from the shareholders' meeting [2] Group 2 - The adjusted conversion price will not be lower than the higher of the average trading price over the 20 trading days prior to the shareholders' meeting and the trading price on the last trading day, and it must also not be lower than the latest audited net asset value per share and the par value of the stock [2] - If any of the aforementioned indicators exceed the current conversion price of 12.50 yuan per share at the time of the shareholders' meeting, no adjustment will be made [2] - The Board requested authorization from the shareholders' meeting to handle all matters related to the downward adjustment of the conversion price, including determining the new conversion price and effective date [2][3]

Meeting Information - The company will hold its second extraordinary general meeting of shareholders in 2025 on July 7, 2025, at 14:00 [1] - Shareholders can participate either in person or via online voting through the Shenzhen Stock Exchange system on the same day [1][2] - The voting options include attending the meeting in person or appointing a proxy to vote on their behalf [2] Voting Procedures - Shareholders can only choose one voting method: either in-person or online voting, with the first valid vote being counted in case of duplicate votes [2] - The meeting will include a proposal to adjust the conversion price of the "Blue Sail Convertible Bond," which requires a two-thirds majority from attending shareholders to pass [3] Registration and Participation - Individual shareholders must present valid identification and proof of share ownership to register for the meeting [4] - Corporate shareholders must be represented by their legal representatives or authorized agents, who must also provide necessary documentation [4] Online Voting Process - Detailed procedures for online voting are provided, allowing shareholders to express their voting opinions on various proposals [5] - The online voting system can be accessed through the specified URL, and shareholders must complete identity verification to participate [5] Contact Information - For inquiries, shareholders can contact the company representatives via provided phone numbers and email [5]

Core Viewpoint - The company proposes to lower the conversion price of its convertible bonds, "蓝帆转债," due to the stock price falling below 85% of the current conversion price for at least 15 out of 30 consecutive trading days [1][4]. Group 1: Convertible Bond Issuance and Adjustment - The total amount of the convertible bonds issued by the company is 314.404 million yuan, approved by the China Securities Regulatory Commission [1]. - The initial conversion price of "蓝帆转债" was set at 17.79 yuan per share, which was later adjusted to 18.64 yuan per share after the company repurchased and canceled 48,148,336 shares [2]. - The board of directors has decided to lower the conversion price to 12.50 yuan per share, effective from May 21, 2024 [3]. Group 2: Conditions for Price Adjustment - The adjustment of the conversion price is triggered when the company's stock price falls below 85% of the current conversion price for at least 15 trading days within a 30-day period [3][4]. - The adjusted conversion price must not be lower than the higher of the average stock price over the 20 trading days prior to the shareholders' meeting and the previous trading day's average price, as well as not lower than the latest audited net asset value per share and the par value of the stock [5]. Group 3: Shareholder Approval and Process - The proposal to adjust the conversion price requires approval from more than two-thirds of the voting rights held by shareholders present at the meeting, excluding those holding the convertible bonds [3][4]. - The company will publish the resolution of the shareholders' meeting, including the adjustment range, registration date, and any suspension of conversion [4].

证券代码：002382 证券简称：蓝帆医疗 公告编号：2025-052 关于召开 2025 年第二次临时股东会的通知 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、 误导性陈述或重大遗漏。 经蓝帆医疗股份有限公司（以下简称"公司"或"本公司"）第六届董事会第二十 四次会议审议通过，公司决定于2025年7月7日召开2025年第二次临时股东会，现将有 关事项通知如下： 一、召开会议基本情况 债券代码：128108 债券简称：蓝帆转债 蓝帆医疗股份有限公司 1、股东会届次：2025 年第二次临时股东会 2、股东会的召集人：公司第六届董事会 3、会议召开的合法、合规性：本次召开股东会的议案经公司第六届董事会第二十 四次会议审议通过，符合有关法律法规、深圳证券交易所业务规则和《蓝帆医疗股份有 限公司章程》的规定。 4、会议召开的日期、时间： 6、股权登记日：2025 年 6 月 30 日（星期一）。 （1）现场会议时间：2025 年 7 月 7 日（星期一）下午 14：00 （2）网络投票时间：2025 年 7 月 7 日 通过深圳证券交易所（以下简称"深交所"）交易系统进行网络投票的具体时间 ...

| 证券代码：002382 | 证券简称：蓝帆医疗 | 公告编号：2025-050 | | --- | --- | --- | | 债券代码：128108 | 债券简称：蓝帆转债 | | 蓝帆医疗股份有限公司 第六届董事会第二十四次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、 误导性陈述或重大遗漏。 一、董事会会议召开情况 蓝帆医疗股份有限公司（以下简称"公司"）第六届董事会第二十四次会议于 2025 年 6 月 17 日以电子邮件的方式发出通知，于 2025 年 6 月 19 日以通讯表决的方式召 开。本次会议应参加会议董事 8 人，实际参加会议董事 8 人，全体董事以通讯的方式 出席会议。公司董事长刘文静女士主持了本次会议。会议的通知、召开、表决程序符合 《中华人民共和国公司法》和《蓝帆医疗股份有限公司章程》的规定。 二、董事会会议审议情况 1、审议并通过了《关于董事会提议向下修正"蓝帆转债"转股价格的议案》； 本议案尚需提交股东会审议。 表决结果：同意票 8 票，反对票 0 票，弃权票 0 票。 具体内容详见刊登于公司指定的信息披露媒体《中国证券报》、《上海证券 ...

本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、 误导性陈述或重大遗漏。 特别提示： 1、截至 2025 年 6 月 19 日，蓝帆医疗股份有限公司（以下简称"公司"）股价已 出现连续三十个交易日中至少有十五个交易日的收盘价低于当期转股价格 85%的情形， 已触发"蓝帆转债"转股价格向下修正条件。 2、经公司第六届董事会第二十四次会议审议通过，公司董事会提议向下修正 "蓝帆转债"转股价格。 3、本次向下修正"蓝帆转债"转股价格的提议尚需提交公司股东会审议。 | 证券代码：002382 | 证券简称：蓝帆医疗 公告编号：2025-051 | | --- | --- | | 债券代码：128108 | 债券简称：蓝帆转债 | 蓝帆医疗股份有限公司 关于董事会提议向下修正"蓝帆转债"转股价格的公告 根据《蓝帆医疗股份有限公司公开发行可转换公司债券募集说明书》的规定，本 次发行的可转债转股期自可转债发行结束之日（2020 年 6 月 3 日）满六个月后的第一个 交易日（2020 年12 月 3 日）起至可转债到期日（2026 年 5 月27 日）止。 （四）可转债转股价格调整情况 1、公司于 ...

Group 1: Economic and Industrial Strength - Weifang is a manufacturing powerhouse, accounting for approximately 10% of the province's total manufacturing output and 1% of the national total [2] - The city has 37 out of 41 industrial categories in the national economy, including key sectors such as power equipment, high-end chemicals, and automotive manufacturing [2] - The industrial output value of large-scale enterprises has exceeded 1 trillion yuan for four consecutive years, with a projected growth of 8.5% in 2024, surpassing the provincial average by 0.2 percentage points [2] Group 2: Innovation and Technology - As of 2024, Weifang has 2,196 high-tech enterprises and 1,228 specialized and innovative companies, showcasing its strong innovation capabilities [3] - The city is actively developing emerging industries such as the metaverse and magnetic technology, promoting the transformation of manufacturing towards high-end, intelligent, and green development [3] Group 3: Agricultural Development - Weifang is recognized as a national agricultural hub, contributing significantly to the country's vegetable and agricultural product exports, with 16.8% of vegetables and 21.4% of agricultural product exports coming from the region [6][7] - The city has modernized its agricultural practices, with over 15,700 modern vegetable greenhouses and a significant portion of its vegetable base utilizing smart greenhouse technology [6] Group 4: International Cooperation and Trade - In 2024, Weifang organized the "Choose Shandong" multinational corporation event, facilitating discussions between 38 Fortune 500 companies and local enterprises, enhancing international cooperation [9] - The city achieved a total import and export value of 153.94 billion yuan in the first five months of 2025, reflecting a year-on-year growth of 5.1% [10] - Weifang has established investment relationships with 92 countries and regions, and its enterprises are involved in overseas projects in 72 countries [12]